• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.

作者信息

Kurth K, Schroeder F H, Debruyne F, Senge T, Pavone-Macaluso M, de Pauw M, ten Kate F, Sylvester R

机构信息

Dept. of Urology, University of Amsterdam, NL.

出版信息

Prog Clin Biol Res. 1989;303:481-90.

PMID:2675005
Abstract
摘要

相似文献

1
Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.
Prog Clin Biol Res. 1989;303:481-90.
2
Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
Prog Clin Biol Res. 1985;185B:135-42.
3
Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.浅表性移行细胞膀胱癌的辅助化疗:欧洲癌症研究与治疗组织的初步结果。比较盐酸阿霉素、环氧氯丙烷与单纯经尿道切除术的随机试验。
J Urol. 1984 Aug;132(2):258-62. doi: 10.1016/s0022-5347(17)49582-6.
4
[Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].[经尿道浅表性膀胱癌切除术后使用Epodyl进行短期与长期化学预防复发的研究]
Urologe A. 1989 Mar;28(2):99-102.
5
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.表浅性移行细胞膀胱癌的辅助化疗:一项欧洲癌症研究与治疗组织的随机试验的长期结果,该试验比较了阿霉素、环氧乳醚和单纯经尿道切除术。
J Urol. 1997 Aug;158(2):378-84. doi: 10.1016/s0022-5347(01)64484-7.
6
Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Prog Clin Biol Res. 1988;269:525-37.
7
BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.卡介苗(荷兰国家公共卫生与环境研究所株)与丝裂霉素膀胱内灌注治疗浅表性膀胱癌患者的疗效比较。欧洲癌症研究与治疗组织泌尿生殖系统肿瘤协作组和荷兰东南部协作组
Prog Clin Biol Res. 1989;303:435-46.
8
Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.膀胱内化疗对复发性浅表性膀胱移行细胞癌复发率的影响:一项荟萃分析的结果
Anticancer Res. 2001 Jan-Feb;21(1B):765-9.
9
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.荷兰合作试验最新情况:丝裂霉素与卡介苗-蒂策株菌对比卡介苗-荷兰国家公共卫生与环境研究所菌株治疗pTA-pT1期乳头状癌及膀胱原位癌患者。荷兰东南部合作泌尿外科组
Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.
10
Early adjuvant adriamycin in superficial bladder carcinoma.早期辅助性阿霉素治疗浅表性膀胱癌。
Prog Clin Biol Res. 1984;162B:151-62.

引用本文的文献

1
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.膀胱、输尿管及肾盂癌标本的处理与病理报告。欧洲泌尿病理学会和泌尿病理工作组联合提议
Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8.
2
Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG).表柔比星预防浅表性膀胱癌的前瞻性随机研究:中央病理实验室的作用。奈良泌尿肿瘤研究组(NUORG)。
Cancer Chemother Pharmacol. 1994;35 Suppl:S36-40. doi: 10.1007/BF00686917.